We used TIMER to evaluate the influence of immune cell infiltration on the clinical prognosis of BC patients, and found that low levels of B cells, CD8+ T cells, CD4+ T cells, neutrophils, and dendritic cells were all related to the poor prognosis of BC patients. This evidence concerns the gene CD4 and breast cancer.